W. Zhao, MD, MS

Articles by W. Zhao, MD, MS

Therapeutic Ratio of Hypofractionation in Early Glottic Cancer: A Topic Worth Revisiting?

ByMichael T. Scott, MD, MBA,Austin Dosch, MD,Nagy Elsayyad, MD,Matthew C. Abramowitz, MD,Arnold M. Markoe, MD,Deukwoo Kwon, PhD,W. Zhao, MD, MS,Michael A. Samuels, MD

September 29th 2015

A retrospective experience suggests that early glottic cancer treated with HRT results in a higher incidence of acute toxicity without improved control compared to CRT delivered in an appropriate OTT.

Latest Updated Articles

$Therapeutic Ratio of Hypofractionation in Early Glottic Cancer: A Topic Worth Revisiting?$
Therapeutic Ratio of Hypofractionation in Early Glottic Cancer: A Topic Worth Revisiting?
September 29th 2015

W. Zhao, MD, MS

Articles by W. Zhao, MD, MS

Therapeutic Ratio of Hypofractionation in Early Glottic Cancer: A Topic Worth Revisiting?

Latest Updated Articles

Trending on OncLive

FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC

Revisit Every OncLive On Air Episode From June 2026

FDA Flashback: Breast Cancer Decisions and News From June 2026

Risvutatug Rezetecan Shows OS Benefit Over Topotecan in Relapsed SCLC

FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma